Viridos

Valuation $1B

About Viridos

Viridos develops genomic-driven solutions to address global energy and environmental challenges.
Headquarters Viridos, La Jolla
Founded 2005-01-01
Industry Biotechnology, Health Care, Medical, Renewable Energy
Last Funding Type Series A
Valuation 1
Total Funding $202.00 million dollars
IPO Status Private

Financial

Viridos may be growing as it is listed among prominent players in the algae biofuel industry, which is projected to reach an $18.84 billion market by 2033. This inclusion suggests that Viridos is recognized in its field and may be contributing to the industry's expansion. Furthermore, the algae biofuel sector's significant market size projection indicates a growing demand for renewable energy solutions, which could benefit Viridos given its operational focus in this area.
Viridos is focused on developing genetically modified algae to enhance lipid and biomass productivity. Their research includes creating recombinant algal mutants with modifications in genes encoding WD40 repeat proteins, trehalose biosynthetic enzymes, and protein kinase-like proteins. These modifications result in higher lipid and biomass productivity. Additionally, they explore mutant photosynthetic microorganisms with reduced chlorophyll for increased productivity and Chlorophyte algae with improved productivity through genetic modifications in chloroplastic signal recognition particles.
Funding Rounds 10
Number of Lead Investors 5
Total Funding Amount  $202.00 million dollars
Number of Investors 12

Related Angels

Jean Hammond
View profile